WEBVTT - GSK Jumps, Astrazeneca Up

0:00:02.540 --> 0:00:06.230
<v Speaker 1>Bloomberg Audio Studios. Podcasts. Radio.

0:00:06.670 --> 0:00:07.070
<v Speaker 2>News.

0:00:08.550 --> 0:00:12.430
<v Speaker 1>The Stock Movers Report. Your roundup of companies making moves

0:00:12.490 --> 0:00:15.870
<v Speaker 1>in the stock market. Harnessing the power of Bloomberg data.

0:00:16.489 --> 0:00:17.910
<v Speaker 1>Let's take a look at some stocks on the move

0:00:17.930 --> 0:00:20.310
<v Speaker 1>today in Europe. I'm Stephen Cowell with Caroline Hepker and

0:00:20.329 --> 0:00:23.550
<v Speaker 1>we're joined by Bloomberg reporter Tiwa Adebayo. Tiwa, let's start

0:00:23.660 --> 0:00:26.240
<v Speaker 1>with pharma and a jump in GSK shares.

0:00:26.960 --> 0:00:29.840
<v Speaker 2>Yes, we've seen GSK shares rising about as much as 2.8%

0:00:29.840 --> 0:00:32.879
<v Speaker 2>this morning. And that's all got to do with some

0:00:32.960 --> 0:00:37.010
<v Speaker 2>positive data that is recorded from recent drug trials. So,

0:00:37.270 --> 0:00:40.640
<v Speaker 2>it's reported positive data in a mid-stage trial for a

0:00:40.690 --> 0:00:45.350
<v Speaker 2>drug for non-small cell lung cancer. That drug is called Judatro.

0:00:46.610 --> 0:00:50.910
<v Speaker 2>In terms of those results, GSK has announced that this

0:00:50.930 --> 0:00:56.150
<v Speaker 2>drug has achieved a 94% objective response rate in terms

0:00:56.430 --> 0:01:01.270
<v Speaker 2>of patients with no placebo comparator, and they are planning

0:01:01.350 --> 0:01:05.250
<v Speaker 2>a supplemental new drug application to the FDA this year

0:01:05.450 --> 0:01:08.429
<v Speaker 2>for that drug. They've also had some good news in

0:01:08.470 --> 0:01:12.610
<v Speaker 2>terms of their partner, Hanso Pharmaceutical. They've said that a

0:01:12.690 --> 0:01:16.709
<v Speaker 2>late-stage trial of another medicine has helped to reduce the

0:01:16.870 --> 0:01:21.480
<v Speaker 2>risk of death by 54% in Chinese patients. with a

0:01:21.560 --> 0:01:25.020
<v Speaker 2>type of small cell lung cancer too. So, some positive

0:01:25.100 --> 0:01:28.660
<v Speaker 2>news there for GSK in terms of new drug trials

0:01:28.680 --> 0:01:31.440
<v Speaker 2>that is driving their shares up this morning. Meanwhile, there's

0:01:31.500 --> 0:01:35.390
<v Speaker 2>also some news from GSK's rival AstraZeneca. Yeah, this is

0:01:35.410 --> 0:01:40.050
<v Speaker 2>an interesting one, Caroline. We're seeing AstraZeneca moving upwards just

0:01:40.150 --> 0:01:43.050
<v Speaker 2>under 2% so far this morning. But I do think

0:01:43.090 --> 0:01:45.369
<v Speaker 2>this is one to watch because they've actually had some

0:01:45.470 --> 0:01:50.690
<v Speaker 2>bad news So we heard on Friday that a recent

0:01:51.010 --> 0:01:54.820
<v Speaker 2>breast cancer pill trial has failed and it could cut

0:01:54.980 --> 0:01:58.420
<v Speaker 2>several billion dollars from the drug's potential sales. That's according

0:01:58.800 --> 0:02:01.640
<v Speaker 2>to analysts. So the drug failed to delay the disease

0:02:01.680 --> 0:02:05.580
<v Speaker 2>progression more than the standard treatment in a late stage situation.

0:02:05.740 --> 0:02:09.540
<v Speaker 2>study uh as i mentioned shares slightly up this morning

0:02:09.639 --> 0:02:14.209
<v Speaker 2>but bloomberg intelligence analysts saying this failure could reduce 2035

0:02:14.210 --> 0:02:19.070
<v Speaker 2>sales by between 2.6 billion dollars and 3.8 billion dollars

0:02:19.110 --> 0:02:22.910
<v Speaker 2>so the shares up so far but definitely something to

0:02:22.970 --> 0:02:26.709
<v Speaker 2>watch as analysts get to grips with that news later

0:02:26.750 --> 0:02:27.490
<v Speaker 2>on this morning.

0:02:28.900 --> 0:02:32.940
<v Speaker 1>The Stock Movers Report from Bloomberg Radio. Check back with

0:02:33.020 --> 0:02:35.540
<v Speaker 1>us throughout the day for the latest roundup of companies

0:02:35.639 --> 0:02:39.590
<v Speaker 1>making news on Wall Street. And for the latest market-moving headlines,

0:02:39.889 --> 0:02:44.410
<v Speaker 1>listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,

0:02:44.630 --> 0:02:47.590
<v Speaker 1>and on Apple CarPlay and Android Auto with the Bloomberg

0:02:47.630 --> 0:02:48.270
<v Speaker 1>Business app.